Alan Kivitz
Impact in
- Rheumatology top 0.02%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Osteoarthritis Treatment and Mechanisms
- Hematology top 0.1%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 190
- Rheumatoid Arthritis Research and Therapies 134
- Spondyloarthritis Studies and Treatments 60
- Systemic Lupus Erythematosus Research 28
- Hematology 77
- Autoimmune and Inflammatory Disorders Research 66
- Co-authors
- Désirée van der HeijdeStanley CohenPhilip J. MeaseJürgen BraunFrancis X. BurchMaxime DougadosWayne TsujiRoy Fleischmann
- Journals
- Annals of the Rheumatic Diseases (65 papers)Rheumatology and Therapy (21 papers)Arthritis & Rheumatology (18 papers)Lara D. Veeken (16 papers)Clinical Therapeutics (8 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Alan Kivitz
256 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Rheumatology 7.4k
- Hematology 3.3k
- Immunology 4.5k
- Orthopedics and Sports Medicine 1.1k
- Pharmacology 1.7k
Countries citing papers authored by Alan Kivitz
This map shows the geographic impact of Alan Kivitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Kivitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Kivitz more than expected).
Fields of papers citing papers by Alan Kivitz
This network shows the impact of papers produced by Alan Kivitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Kivitz. The network helps show where Alan Kivitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Kivitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 40 | |
| 14 | Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study | 2021 | 0 |
| 15 | 2020 | 97 | |
| 16 | 2020 | 26 | |
| 17 | Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. | 2017 | 69 |
| 18 | A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO | 2011 | 1 |
| 19 | 2006 | 16 | |
| 20 | Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. | 2002 | 89 |
About Alan Kivitz
Alan Kivitz is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Pharmacology, having authored 266 papers that have together received 12.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (134 papers), Autoimmune and Inflammatory Disorders Research (66 papers), Spondyloarthritis Studies and Treatments (60 papers), Psoriasis: Treatment and Pathogenesis (48 papers), Chronic Lymphocytic Leukemia Research (43 papers), Inflammatory mediators and NSAID effects (37 papers), Monoclonal and Polyclonal Antibodies Research (36 papers) and Systemic Lupus Erythematosus Research (28 papers). The work is most often cited by research in Rheumatology (7.4k citations), Hematology (3.3k citations), Immunology (4.5k citations), Orthopedics and Sports Medicine (1.1k citations) and Pharmacology (1.7k citations). Alan Kivitz has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Désirée van der Heijde, Stanley Cohen, Philip J. Mease, Jürgen Braun, Francis X. Burch, Maxime Dougados, Wayne Tsuji, Roy Fleischmann, John C. Davis and Mark C. Genovese. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, Arthritis & Rheumatology, Lara D. Veeken and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.